Global Acute Myeloid Leukemia Biomarker Detection Market Growth 2026-2032

October 2026 | 96 pages | ID: G988BE87FE73EN
LP Information

Abstracts

The global Acute Myeloid Leukemia Biomarker Detection market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

Acute myeloid leukemia is a malignant neoplastic disease that usually results from the deterioration of stem cells in the bone marrow. Biomarker detection is a method that can detect specific molecular or genetic variations of leukemia cells, which can be used to diagnose AML, evaluate patient prognosis, and guide the selection of treatment options.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

LP Information, Inc. (LPI) ' newest research report, the “Acute Myeloid Leukemia Biomarker Detection Industry Forecast” looks at past sales and reviews total world Acute Myeloid Leukemia Biomarker Detection sales in 2025, providing a comprehensive analysis by region and market sector of projected Acute Myeloid Leukemia Biomarker Detection sales for 2026 through 2032. With Acute Myeloid Leukemia Biomarker Detection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Acute Myeloid Leukemia Biomarker Detection industry.

This Insight Report provides a comprehensive analysis of the global Acute Myeloid Leukemia Biomarker Detection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Acute Myeloid Leukemia Biomarker Detection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Acute Myeloid Leukemia Biomarker Detection market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Acute Myeloid Leukemia Biomarker Detection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Acute Myeloid Leukemia Biomarker Detection.

This report presents a comprehensive overview, market shares, and growth opportunities of Acute Myeloid Leukemia Biomarker Detection market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Next Generation Sequencing Technology
• PCR Detection Technology

Segmentation by Application:

• Hospital
• Research Institutions
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Abbott Laboratories
• Bio-Rad Laboratories, Inc.
• Genmark Saghlk Orinleri
• Laboratory Corporation of America Holdings
• Danaher
• Medaysis Company
• NeoGenomics Laboratories
• QIAGEN N.V.
• Thermo Fisher Scientific, Inc.
• GeneTex

Key Questions Addressed in this Report

• What is the 10-year outlook for the global Acute Myeloid Leukemia Biomarker Detection market?
• What factors are driving Acute Myeloid Leukemia Biomarker Detection market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Acute Myeloid Leukemia Biomarker Detection market opportunities vary by end market size?
• How does Acute Myeloid Leukemia Biomarker Detection break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Acute Myeloid Leukemia Biomarker Detection Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Acute Myeloid Leukemia Biomarker Detection by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Acute Myeloid Leukemia Biomarker Detection by Country/Region, 2021, 2025 & 2032
2.2 Acute Myeloid Leukemia Biomarker Detection Segment by Type
  2.2.1 Next Generation Sequencing Technology
  2.2.2 PCR Detection Technology
  2.2.3 Acute Myeloid Leukemia Biomarker Detection Sales by Type
    2.2.3.1 Global Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Type (2021-2026)
    2.2.3.2 Global Acute Myeloid Leukemia Biomarker Detection Revenue and Market Share by Type (2021-2026)
    2.2.3.3 Global Acute Myeloid Leukemia Biomarker Detection Sale Price by Type (2021-2026)
2.3 Acute Myeloid Leukemia Biomarker Detection Segment by Application
  2.3.1 Hospital
  2.3.2 Research Institutions
  2.3.3 Other
  2.3.4 Acute Myeloid Leukemia Biomarker Detection Sales by Application
    2.3.4.1 Global Acute Myeloid Leukemia Biomarker Detection Sale Market Share by Application (2021-2026)
    2.3.4.2 Global Acute Myeloid Leukemia Biomarker Detection Revenue and Market Share by Application (2021-2026)
    2.3.4.3 Global Acute Myeloid Leukemia Biomarker Detection Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Acute Myeloid Leukemia Biomarker Detection Breakdown Data by Company
  3.1.1 Global Acute Myeloid Leukemia Biomarker Detection Annual Sales by Company (2021-2026)
  3.1.2 Global Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Company (2021-2026)
3.2 Global Acute Myeloid Leukemia Biomarker Detection Annual Revenue by Company (2021-2026)
  3.2.1 Global Acute Myeloid Leukemia Biomarker Detection Revenue by Company (2021-2026)
  3.2.2 Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Company (2021-2026)
3.3 Global Acute Myeloid Leukemia Biomarker Detection Sale Price by Company
3.4 Key Manufacturers Acute Myeloid Leukemia Biomarker Detection Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Acute Myeloid Leukemia Biomarker Detection Product Location Distribution
  3.4.2 Players Acute Myeloid Leukemia Biomarker Detection Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR ACUTE MYELOID LEUKEMIA BIOMARKER DETECTION BY GEOGRAPHIC REGION

4.1 World Historic Acute Myeloid Leukemia Biomarker Detection Market Size by Geographic Region (2021-2026)
  4.1.1 Global Acute Myeloid Leukemia Biomarker Detection Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Acute Myeloid Leukemia Biomarker Detection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Acute Myeloid Leukemia Biomarker Detection Market Size by Country/Region (2021-2026)
  4.2.1 Global Acute Myeloid Leukemia Biomarker Detection Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Acute Myeloid Leukemia Biomarker Detection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Acute Myeloid Leukemia Biomarker Detection Sales Growth
4.4 APAC Acute Myeloid Leukemia Biomarker Detection Sales Growth
4.5 Europe Acute Myeloid Leukemia Biomarker Detection Sales Growth
4.6 Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Sales Growth

5 AMERICAS

5.1 Americas Acute Myeloid Leukemia Biomarker Detection Sales by Country
  5.1.1 Americas Acute Myeloid Leukemia Biomarker Detection Sales by Country (2021-2026)
  5.1.2 Americas Acute Myeloid Leukemia Biomarker Detection Revenue by Country (2021-2026)
5.2 Americas Acute Myeloid Leukemia Biomarker Detection Sales by Type (2021-2026)
5.3 Americas Acute Myeloid Leukemia Biomarker Detection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Acute Myeloid Leukemia Biomarker Detection Sales by Region
  6.1.1 APAC Acute Myeloid Leukemia Biomarker Detection Sales by Region (2021-2026)
  6.1.2 APAC Acute Myeloid Leukemia Biomarker Detection Revenue by Region (2021-2026)
6.2 APAC Acute Myeloid Leukemia Biomarker Detection Sales by Type (2021-2026)
6.3 APAC Acute Myeloid Leukemia Biomarker Detection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Acute Myeloid Leukemia Biomarker Detection by Country
  7.1.1 Europe Acute Myeloid Leukemia Biomarker Detection Sales by Country (2021-2026)
  7.1.2 Europe Acute Myeloid Leukemia Biomarker Detection Revenue by Country (2021-2026)
7.2 Europe Acute Myeloid Leukemia Biomarker Detection Sales by Type (2021-2026)
7.3 Europe Acute Myeloid Leukemia Biomarker Detection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Acute Myeloid Leukemia Biomarker Detection by Country
  8.1.1 Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Revenue by Country (2021-2026)
8.2 Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Sales by Type (2021-2026)
8.3 Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Acute Myeloid Leukemia Biomarker Detection
10.3 Manufacturing Process Analysis of Acute Myeloid Leukemia Biomarker Detection
10.4 Industry Chain Structure of Acute Myeloid Leukemia Biomarker Detection

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Acute Myeloid Leukemia Biomarker Detection Distributors
11.3 Acute Myeloid Leukemia Biomarker Detection Customer

12 WORLD FORECAST REVIEW FOR ACUTE MYELOID LEUKEMIA BIOMARKER DETECTION BY GEOGRAPHIC REGION

12.1 Global Acute Myeloid Leukemia Biomarker Detection Market Size Forecast by Region
  12.1.1 Global Acute Myeloid Leukemia Biomarker Detection Forecast by Region (2027-2032)
  12.1.2 Global Acute Myeloid Leukemia Biomarker Detection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Acute Myeloid Leukemia Biomarker Detection Forecast by Type (2027-2032)
12.7 Global Acute Myeloid Leukemia Biomarker Detection Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Abbott Laboratories
  13.1.1 Abbott Laboratories Company Information
  13.1.2 Abbott Laboratories Acute Myeloid Leukemia Biomarker Detection Product Portfolios and Specifications
  13.1.3 Abbott Laboratories Acute Myeloid Leukemia Biomarker Detection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Abbott Laboratories Main Business Overview
  13.1.5 Abbott Laboratories Latest Developments
13.2 Bio-Rad Laboratories, Inc.
  13.2.1 Bio-Rad Laboratories, Inc. Company Information
  13.2.2 Bio-Rad Laboratories, Inc. Acute Myeloid Leukemia Biomarker Detection Product Portfolios and Specifications
  13.2.3 Bio-Rad Laboratories, Inc. Acute Myeloid Leukemia Biomarker Detection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Bio-Rad Laboratories, Inc. Main Business Overview
  13.2.5 Bio-Rad Laboratories, Inc. Latest Developments
13.3 Genmark Saghlk Orinleri
  13.3.1 Genmark Saghlk Orinleri Company Information
  13.3.2 Genmark Saghlk Orinleri Acute Myeloid Leukemia Biomarker Detection Product Portfolios and Specifications
  13.3.3 Genmark Saghlk Orinleri Acute Myeloid Leukemia Biomarker Detection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Genmark Saghlk Orinleri Main Business Overview
  13.3.5 Genmark Saghlk Orinleri Latest Developments
13.4 Laboratory Corporation of America Holdings
  13.4.1 Laboratory Corporation of America Holdings Company Information
  13.4.2 Laboratory Corporation of America Holdings Acute Myeloid Leukemia Biomarker Detection Product Portfolios and Specifications
  13.4.3 Laboratory Corporation of America Holdings Acute Myeloid Leukemia Biomarker Detection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 Laboratory Corporation of America Holdings Main Business Overview
  13.4.5 Laboratory Corporation of America Holdings Latest Developments
13.5 Danaher
  13.5.1 Danaher Company Information
  13.5.2 Danaher Acute Myeloid Leukemia Biomarker Detection Product Portfolios and Specifications
  13.5.3 Danaher Acute Myeloid Leukemia Biomarker Detection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 Danaher Main Business Overview
  13.5.5 Danaher Latest Developments
13.6 Medaysis Company
  13.6.1 Medaysis Company Company Information
  13.6.2 Medaysis Company Acute Myeloid Leukemia Biomarker Detection Product Portfolios and Specifications
  13.6.3 Medaysis Company Acute Myeloid Leukemia Biomarker Detection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 Medaysis Company Main Business Overview
  13.6.5 Medaysis Company Latest Developments
13.7 NeoGenomics Laboratories
  13.7.1 NeoGenomics Laboratories Company Information
  13.7.2 NeoGenomics Laboratories Acute Myeloid Leukemia Biomarker Detection Product Portfolios and Specifications
  13.7.3 NeoGenomics Laboratories Acute Myeloid Leukemia Biomarker Detection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 NeoGenomics Laboratories Main Business Overview
  13.7.5 NeoGenomics Laboratories Latest Developments
13.8 QIAGEN N.V.
  13.8.1 QIAGEN N.V. Company Information
  13.8.2 QIAGEN N.V. Acute Myeloid Leukemia Biomarker Detection Product Portfolios and Specifications
  13.8.3 QIAGEN N.V. Acute Myeloid Leukemia Biomarker Detection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.8.4 QIAGEN N.V. Main Business Overview
  13.8.5 QIAGEN N.V. Latest Developments
13.9 Thermo Fisher Scientific, Inc.
  13.9.1 Thermo Fisher Scientific, Inc. Company Information
  13.9.2 Thermo Fisher Scientific, Inc. Acute Myeloid Leukemia Biomarker Detection Product Portfolios and Specifications
  13.9.3 Thermo Fisher Scientific, Inc. Acute Myeloid Leukemia Biomarker Detection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.9.4 Thermo Fisher Scientific, Inc. Main Business Overview
  13.9.5 Thermo Fisher Scientific, Inc. Latest Developments
13.10 GeneTex
  13.10.1 GeneTex Company Information
  13.10.2 GeneTex Acute Myeloid Leukemia Biomarker Detection Product Portfolios and Specifications
  13.10.3 GeneTex Acute Myeloid Leukemia Biomarker Detection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.10.4 GeneTex Main Business Overview
  13.10.5 GeneTex Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Acute Myeloid Leukemia Biomarker Detection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Acute Myeloid Leukemia Biomarker Detection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Next Generation Sequencing Technology
Table 4. Major Players of PCR Detection Technology
Table 5. Global Acute Myeloid Leukemia Biomarker Detection Sales by Type (2021-2026) & (K Units)
Table 6. Global Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Type (2021-2026)
Table 7. Global Acute Myeloid Leukemia Biomarker Detection Revenue by Type (2021-2026) & ($ million)
Table 8. Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Type (2021-2026)
Table 9. Global Acute Myeloid Leukemia Biomarker Detection Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Acute Myeloid Leukemia Biomarker Detection Sale by Application (2021-2026) & (K Units)
Table 11. Global Acute Myeloid Leukemia Biomarker Detection Sale Market Share by Application (2021-2026)
Table 12. Global Acute Myeloid Leukemia Biomarker Detection Revenue by Application (2021-2026) & ($ million)
Table 13. Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Application (2021-2026)
Table 14. Global Acute Myeloid Leukemia Biomarker Detection Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Acute Myeloid Leukemia Biomarker Detection Sales by Company (2021-2026) & (K Units)
Table 16. Global Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Company (2021-2026)
Table 17. Global Acute Myeloid Leukemia Biomarker Detection Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Company (2021-2026)
Table 19. Global Acute Myeloid Leukemia Biomarker Detection Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Acute Myeloid Leukemia Biomarker Detection Producing Area Distribution and Sales Area
Table 21. Players Acute Myeloid Leukemia Biomarker Detection Products Offered
Table 22. Acute Myeloid Leukemia Biomarker Detection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Acute Myeloid Leukemia Biomarker Detection Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Acute Myeloid Leukemia Biomarker Detection Sales Market Share Geographic Region (2021-2026)
Table 27. Global Acute Myeloid Leukemia Biomarker Detection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Acute Myeloid Leukemia Biomarker Detection Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Country/Region (2021-2026)
Table 31. Global Acute Myeloid Leukemia Biomarker Detection Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Acute Myeloid Leukemia Biomarker Detection Sales by Country (2021-2026) & (K Units)
Table 34. Americas Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Country (2021-2026)
Table 35. Americas Acute Myeloid Leukemia Biomarker Detection Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Acute Myeloid Leukemia Biomarker Detection Sales by Type (2021-2026) & (K Units)
Table 37. Americas Acute Myeloid Leukemia Biomarker Detection Sales by Application (2021-2026) & (K Units)
Table 38. APAC Acute Myeloid Leukemia Biomarker Detection Sales by Region (2021-2026) & (K Units)
Table 39. APAC Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Region (2021-2026)
Table 40. APAC Acute Myeloid Leukemia Biomarker Detection Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Acute Myeloid Leukemia Biomarker Detection Sales by Type (2021-2026) & (K Units)
Table 42. APAC Acute Myeloid Leukemia Biomarker Detection Sales by Application (2021-2026) & (K Units)
Table 43. Europe Acute Myeloid Leukemia Biomarker Detection Sales by Country (2021-2026) & (K Units)
Table 44. Europe Acute Myeloid Leukemia Biomarker Detection Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Acute Myeloid Leukemia Biomarker Detection Sales by Type (2021-2026) & (K Units)
Table 46. Europe Acute Myeloid Leukemia Biomarker Detection Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Acute Myeloid Leukemia Biomarker Detection
Table 52. Key Market Challenges & Risks of Acute Myeloid Leukemia Biomarker Detection
Table 53. Key Industry Trends of Acute Myeloid Leukemia Biomarker Detection
Table 54. Acute Myeloid Leukemia Biomarker Detection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Acute Myeloid Leukemia Biomarker Detection Distributors List
Table 57. Acute Myeloid Leukemia Biomarker Detection Customer List
Table 58. Global Acute Myeloid Leukemia Biomarker Detection Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Acute Myeloid Leukemia Biomarker Detection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Acute Myeloid Leukemia Biomarker Detection Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Acute Myeloid Leukemia Biomarker Detection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Acute Myeloid Leukemia Biomarker Detection Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Acute Myeloid Leukemia Biomarker Detection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Acute Myeloid Leukemia Biomarker Detection Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Acute Myeloid Leukemia Biomarker Detection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Acute Myeloid Leukemia Biomarker Detection Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Acute Myeloid Leukemia Biomarker Detection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Acute Myeloid Leukemia Biomarker Detection Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Acute Myeloid Leukemia Biomarker Detection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Abbott Laboratories Basic Information, Acute Myeloid Leukemia Biomarker Detection Manufacturing Base, Sales Area and Its Competitors
Table 73. Abbott Laboratories Acute Myeloid Leukemia Biomarker Detection Product Portfolios and Specifications
Table 74. Abbott Laboratories Acute Myeloid Leukemia Biomarker Detection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Abbott Laboratories Main Business
Table 76. Abbott Laboratories Latest Developments
Table 77. Bio-Rad Laboratories, Inc. Basic Information, Acute Myeloid Leukemia Biomarker Detection Manufacturing Base, Sales Area and Its Competitors
Table 78. Bio-Rad Laboratories, Inc. Acute Myeloid Leukemia Biomarker Detection Product Portfolios and Specifications
Table 79. Bio-Rad Laboratories, Inc. Acute Myeloid Leukemia Biomarker Detection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Bio-Rad Laboratories, Inc. Main Business
Table 81. Bio-Rad Laboratories, Inc. Latest Developments
Table 82. Genmark Saghlk Orinleri Basic Information, Acute Myeloid Leukemia Biomarker Detection Manufacturing Base, Sales Area and Its Competitors
Table 83. Genmark Saghlk Orinleri Acute Myeloid Leukemia Biomarker Detection Product Portfolios and Specifications
Table 84. Genmark Saghlk Orinleri Acute Myeloid Leukemia Biomarker Detection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Genmark Saghlk Orinleri Main Business
Table 86. Genmark Saghlk Orinleri Latest Developments
Table 87. Laboratory Corporation of America Holdings Basic Information, Acute Myeloid Leukemia Biomarker Detection Manufacturing Base, Sales Area and Its Competitors
Table 88. Laboratory Corporation of America Holdings Acute Myeloid Leukemia Biomarker Detection Product Portfolios and Specifications
Table 89. Laboratory Corporation of America Holdings Acute Myeloid Leukemia Biomarker Detection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Laboratory Corporation of America Holdings Main Business
Table 91. Laboratory Corporation of America Holdings Latest Developments
Table 92. Danaher Basic Information, Acute Myeloid Leukemia Biomarker Detection Manufacturing Base, Sales Area and Its Competitors
Table 93. Danaher Acute Myeloid Leukemia Biomarker Detection Product Portfolios and Specifications
Table 94. Danaher Acute Myeloid Leukemia Biomarker Detection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Danaher Main Business
Table 96. Danaher Latest Developments
Table 97. Medaysis Company Basic Information, Acute Myeloid Leukemia Biomarker Detection Manufacturing Base, Sales Area and Its Competitors
Table 98. Medaysis Company Acute Myeloid Leukemia Biomarker Detection Product Portfolios and Specifications
Table 99. Medaysis Company Acute Myeloid Leukemia Biomarker Detection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Medaysis Company Main Business
Table 101. Medaysis Company Latest Developments
Table 102. NeoGenomics Laboratories Basic Information, Acute Myeloid Leukemia Biomarker Detection Manufacturing Base, Sales Area and Its Competitors
Table 103. NeoGenomics Laboratories Acute Myeloid Leukemia Biomarker Detection Product Portfolios and Specifications
Table 104. NeoGenomics Laboratories Acute Myeloid Leukemia Biomarker Detection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. NeoGenomics Laboratories Main Business
Table 106. NeoGenomics Laboratories Latest Developments
Table 107. QIAGEN N.V. Basic Information, Acute Myeloid Leukemia Biomarker Detection Manufacturing Base, Sales Area and Its Competitors
Table 108. QIAGEN N.V. Acute Myeloid Leukemia Biomarker Detection Product Portfolios and Specifications
Table 109. QIAGEN N.V. Acute Myeloid Leukemia Biomarker Detection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. QIAGEN N.V. Main Business
Table 111. QIAGEN N.V. Latest Developments
Table 112. Thermo Fisher Scientific, Inc. Basic Information, Acute Myeloid Leukemia Biomarker Detection Manufacturing Base, Sales Area and Its Competitors
Table 113. Thermo Fisher Scientific, Inc. Acute Myeloid Leukemia Biomarker Detection Product Portfolios and Specifications
Table 114. Thermo Fisher Scientific, Inc. Acute Myeloid Leukemia Biomarker Detection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Thermo Fisher Scientific, Inc. Main Business
Table 116. Thermo Fisher Scientific, Inc. Latest Developments
Table 117. GeneTex Basic Information, Acute Myeloid Leukemia Biomarker Detection Manufacturing Base, Sales Area and Its Competitors
Table 118. GeneTex Acute Myeloid Leukemia Biomarker Detection Product Portfolios and Specifications
Table 119. GeneTex Acute Myeloid Leukemia Biomarker Detection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. GeneTex Main Business
Table 121. GeneTex Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Acute Myeloid Leukemia Biomarker Detection
Figure 2. Acute Myeloid Leukemia Biomarker Detection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Acute Myeloid Leukemia Biomarker Detection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Acute Myeloid Leukemia Biomarker Detection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Acute Myeloid Leukemia Biomarker Detection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Country/Region (2025)
Figure 10. Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Next Generation Sequencing Technology
Figure 12. Product Picture of PCR Detection Technology
Figure 13. Global Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Type in 2026
Figure 14. Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Type (2021-2026)
Figure 15. Acute Myeloid Leukemia Biomarker Detection Consumed in Hospital
Figure 16. Global Acute Myeloid Leukemia Biomarker Detection Market: Hospital (2021-2026) & (K Units)
Figure 17. Acute Myeloid Leukemia Biomarker Detection Consumed in Research Institutions
Figure 18. Global Acute Myeloid Leukemia Biomarker Detection Market: Research Institutions (2021-2026) & (K Units)
Figure 19. Acute Myeloid Leukemia Biomarker Detection Consumed in Other
Figure 20. Global Acute Myeloid Leukemia Biomarker Detection Market: Other (2021-2026) & (K Units)
Figure 21. Global Acute Myeloid Leukemia Biomarker Detection Sale Market Share by Application (2025)
Figure 22. Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Application in 2026
Figure 23. Acute Myeloid Leukemia Biomarker Detection Sales by Company in 2026 (K Units)
Figure 24. Global Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Company in 2026
Figure 25. Acute Myeloid Leukemia Biomarker Detection Revenue by Company in 2026 ($ millions)
Figure 26. Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Company in 2026
Figure 27. Global Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Acute Myeloid Leukemia Biomarker Detection Sales 2021-2026 (K Units)
Figure 30. Americas Acute Myeloid Leukemia Biomarker Detection Revenue 2021-2026 ($ millions)
Figure 31. APAC Acute Myeloid Leukemia Biomarker Detection Sales 2021-2026 (K Units)
Figure 32. APAC Acute Myeloid Leukemia Biomarker Detection Revenue 2021-2026 ($ millions)
Figure 33. Europe Acute Myeloid Leukemia Biomarker Detection Sales 2021-2026 (K Units)
Figure 34. Europe Acute Myeloid Leukemia Biomarker Detection Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Revenue 2021-2026 ($ millions)
Figure 37. Americas Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Country in 2026
Figure 38. Americas Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Country (2021-2026)
Figure 39. Americas Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Type (2021-2026)
Figure 40. Americas Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Application (2021-2026)
Figure 41. United States Acute Myeloid Leukemia Biomarker Detection Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Acute Myeloid Leukemia Biomarker Detection Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Acute Myeloid Leukemia Biomarker Detection Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Acute Myeloid Leukemia Biomarker Detection Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Region in 2026
Figure 46. APAC Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Region (2021-2026)
Figure 47. APAC Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Type (2021-2026)
Figure 48. APAC Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Application (2021-2026)
Figure 49. China Acute Myeloid Leukemia Biomarker Detection Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Acute Myeloid Leukemia Biomarker Detection Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Acute Myeloid Leukemia Biomarker Detection Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Acute Myeloid Leukemia Biomarker Detection Revenue Growth 2021-2026 ($ millions)
Figure 53. India Acute Myeloid Leukemia Biomarker Detection Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Acute Myeloid Leukemia Biomarker Detection Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Acute Myeloid Leukemia Biomarker Detection Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Country in 2026
Figure 57. Europe Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Country (2021-2026)
Figure 58. Europe Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Type (2021-2026)
Figure 59. Europe Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Application (2021-2026)
Figure 60. Germany Acute Myeloid Leukemia Biomarker Detection Revenue Growth 2021-2026 ($ millions)
Figure 61. France Acute Myeloid Leukemia Biomarker Detection Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Acute Myeloid Leukemia Biomarker Detection Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Acute Myeloid Leukemia Biomarker Detection Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Acute Myeloid Leukemia Biomarker Detection Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Application (2021-2026)
Figure 68. Egypt Acute Myeloid Leukemia Biomarker Detection Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Acute Myeloid Leukemia Biomarker Detection Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Acute Myeloid Leukemia Biomarker Detection Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Acute Myeloid Leukemia Biomarker Detection Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Acute Myeloid Leukemia Biomarker Detection Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Acute Myeloid Leukemia Biomarker Detection in 2026
Figure 74. Manufacturing Process Analysis of Acute Myeloid Leukemia Biomarker Detection
Figure 75. Industry Chain Structure of Acute Myeloid Leukemia Biomarker Detection
Figure 76. Channels of Distribution
Figure 77. Global Acute Myeloid Leukemia Biomarker Detection Sales Market Forecast by Region (2027-2032)
Figure 78. Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Acute Myeloid Leukemia Biomarker Detection Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Acute Myeloid Leukemia Biomarker Detection Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share Forecast by Application (2027-2032)